These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2654127)

  • 21. Carbamazepine and lithium: different profiles in affective disorder?
    Lerer B; Moore N; Meyendorff E; Cho SR; Gershon S
    Psychopharmacol Bull; 1985; 21(1):18-22. PubMed ID: 3885293
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lithium in the prophylaxis of recurrent affective disorders. Effectiveness of low plasma levels and predictors to clinical response (author's transl)].
    Faravelli C; Marchetti G; Benvenuti P; Cabras PL
    Riv Patol Nerv Ment; 1980; 101(6):261-71. PubMed ID: 6801749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials.
    Pecenak J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():49-70. PubMed ID: 17262007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
    Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
    Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium studies and manic-depressive illness.
    Fieve RR
    Proc Annu Meet Am Psychopathol Assoc; 1972; 60():135-50. PubMed ID: 4333975
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
    McElroy SL; Bowden CL; Collins MA; Wozniak PJ; Keck PE; Calabrese JR
    J Affect Disord; 2008 Apr; 107(1-3):127-33. PubMed ID: 17888516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipsychotic effects of lithium in schizophrenia.
    Alexander PE; van Kammen DP; Bunney WE
    Am J Psychiatry; 1979 Mar; 136(3):283-7. PubMed ID: 369396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic lithium treatment of drug abuse.
    Náhunek K; Kamenická V; Misurec J; Sláma B; Svestka J; Novotná H
    Act Nerv Super (Praha); 1978 Feb; 20(1):70-2. PubMed ID: 345718
    [No Abstract]   [Full Text] [Related]  

  • 31. Biological factors in affective disorders and their relevance to lithium prophylaxis.
    Mendlewicz J
    Pharmacopsychiatria; 1982 Jan; 15(1):11-8. PubMed ID: 7063525
    [No Abstract]   [Full Text] [Related]  

  • 32. Lithium treatment in post-psychotic depression.
    van Kammen DP; Alexander PE; Bunney WE
    Br J Psychiatry; 1980 May; 136():479-85. PubMed ID: 6992904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A favorable response to lithium carbonate in a "schizo-affective" father and son.
    Reiser DE; Willett AB
    Am J Psychiatry; 1976 Jul; 133(7):824-7. PubMed ID: 937574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of long-term preventive treatment of adolescents with circular schizophrenia by means of lithium salts].
    Iovchuk NM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(8):1230-2. PubMed ID: 899539
    [No Abstract]   [Full Text] [Related]  

  • 35. d-Amphetamine raises serum prolactin in man: evaluations after chronic placebo, lithium and pimozide treatment.
    van Kammen DP; Docherty JP; Marder SR; Siris SG; Bunney WE
    Life Sci; 1978 Oct; 23(14):1487-92. PubMed ID: 362103
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical trial of lithium salts in the states of chronic psychomotor agitation].
    Bukowski J; Janiszewski M
    Psychiatr Pol; 1978; 12(4):533. PubMed ID: 364514
    [No Abstract]   [Full Text] [Related]  

  • 37. Rubidium in psychiatry: research implications.
    Malek-Ahmadi P; Williams JA
    Pharmacol Biochem Behav; 1984; 21 Suppl 1():49-50. PubMed ID: 6522433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium and suicidality revisited.
    Connemann BJ
    Am J Psychiatry; 2006 Mar; 163(3):550; author reply 550-1. PubMed ID: 16513890
    [No Abstract]   [Full Text] [Related]  

  • 39. Mental handicap and double-blind trial design.
    Dark R; Rogers E
    Br J Psychiatry; 1987 Nov; 151():705-7. PubMed ID: 3328639
    [No Abstract]   [Full Text] [Related]  

  • 40. Lithium prophylaxis recurrent affective disorders.
    Melia PI
    Br J Psychiatry; 1971 Jan; 118(542):134-5. PubMed ID: 4930547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.